Bio-Gene Technology Limited (BGT.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 18.32 Thousand | 595.07 Thousand | 879.77 Thousand | 573.11 Thousand | 907.58 Thousand | 508.75 Thousand |
| Cost of Revenue | 319.76 Thousand | 313.27 Thousand | 267.14 Thousand | 173.2 Thousand | 267.12 Thousand | 106.64 Thousand |
| Gross Profit | -301.44 Thousand | 281.8 Thousand | 612.63 Thousand | 399.91 Thousand | 640.45 Thousand | 402.11 Thousand |
| Operating Expenses | 2.76 Million | 3.77 Million | 3.85 Million | 3.03 Million | 3.06 Million | 2.7 Million |
| Selling, General and Administrative Expenses | 1.69 Million | 477.73 Thousand | 513.68 Thousand | 374.57 Thousand | 384.38 Thousand | 348.65 Thousand |
| Research and Development Expenses | 1.07 Million | 1.97 Million | 1.89 Million | 1.67 Million | 1.44 Million | 1.42 Million |
| Other Expenses | - | 250.00 | 1.44 Million | 987.47 Thousand | 1.23 Million | 926.8 Thousand |
| Cost and Expenses | 3.08 Million | 3.77 Million | 3.85 Million | 3.03 Million | 3.06 Million | 2.7 Million |
| Operating Income | -3.06 Million | -3.18 Million | -2.97 Million | -2.46 Million | -2.16 Million | -2.19 Million |
| Interest Expense | - | - | 52.86 Thousand | 337.00 | 1231.00 | - |
| Income Tax Expense | -604.18 Thousand | -85.96 Thousand | -112.2 Thousand | -38.11 Thousand | -63.24 Thousand | -135.84 Thousand |
| Earnings before Tax | -3.01 Million | -3.09 Million | -2.91 Million | -2.39 Million | -1.93 Million | -2.05 Million |
| Net Income | -2.4 Million | -3.09 Million | -2.8 Million | -2.35 Million | -1.86 Million | -1.91 Million |
| Earnings Per Share Basic | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 185.32 Million | 167.76 Million | 153.33 Million | 137.23 Million | 119.37 Million | 117.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 185.81 Million | 167.76 Million | 153.33 Million | 137.23 Million | 119.37 Million | 117.74 Million |
| Gross Margin | -16.45 | 0.47 | 0.70 | 0.70 | 0.71 | 0.79 |
| EBIT Margin | -162.39 | -5.27 | -3.33 | -4.21 | -2.32 | -4.22 |
| Profit Margin | -131.51 | -5.20 | -3.18 | -4.11 | -2.06 | -3.77 |
| EBITDA | -2.97 Million | -3.13 Million | -2.92 Million | -2.39 Million | -2.05 Million | -2.14 Million |
| Earnings Before Tax Margin | -167.17 | -5.35 | -3.38 | -4.30 | -2.38 | -4.31 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | -435.00 | 18.32 Thousand | 18.75 Thousand | 149.23 Thousand | 595.07 Thousand | - |
| Cost of Revenue | 129.52 Thousand | 358.15 Thousand | 190.24 Thousand | 290.43 Thousand | 313.27 Thousand | 22.83 Thousand |
| Gross Profit | -129.96 Thousand | -339.83 Thousand | -171.48 Thousand | -141.2 Thousand | 281.8 Thousand | -22.83 Thousand |
| Operating Expenses | 1.59 Million | 2.76 Million | 1.16 Million | 1.42 Million | 3.77 Million | 2.03 Million |
| Selling, General and Administrative Expenses | 1.24 Million | - | 445.84 Thousand | 669.4 Thousand | - | 815.5 Thousand |
| Research and Development Expenses | 353.34 Thousand | - | 717.06 Thousand | 757.22 Thousand | - | 1.22 Million |
| Other Expenses | - | - | - | - | 250.00 | - |
| Cost and Expenses | 1.72 Million | 3.11 Million | 1.35 Million | 1.71 Million | 3.77 Million | 2.06 Million |
| Operating Income | -1.72 Million | -3.1 Million | -1.33 Million | -1.56 Million | -3.18 Million | -2.06 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 787.83 Thousand | -604.18 Thousand | -104.18 Thousand | -400 Thousand | -85.96 Thousand | -45.84 Thousand |
| Earnings before Tax | -899.96 Thousand | -3.01 Million | -1.5 Million | -1.52 Million | -3.09 Million | -2.01 Million |
| Net Income | -899.96 Thousand | -2.4 Million | -1.5 Million | -1.12 Million | -3.09 Million | -1.97 Million |
| Earnings Per Share Basic | -0.00 | - | -0.01 | -0.01 | - | -0.01 |
| Earnings Per Share Diluted | -0.00 | - | -0.01 | -0.01 | - | -0.01 |
| Weighted Average Shares Outstanding | 190.62 Million | 185.81 Million | 179.66 Million | 177.9 Million | 167.76 Million | 177.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 191.96 Million | 185.81 Million | 179.66 Million | 177.9 Million | 167.76 Million | 177.9 Million |
| Gross Margin | 298.76 | -18.55 | -9.14 | -0.95 | 0.47 | - |
| EBIT Margin | 2124.15 | - | -81.78 | -10.36 | - | - |
| Profit Margin | 2068.88 | -131.51 | -80.47 | -7.54 | -5.20 | - |
| EBITDA | -924 Thousand | - | -1.53 Million | -1.54 Million | - | -2.03 Million |
| Earnings Before Tax Margin | 3972.55 | -169.26 | -71.15 | -10.51 | -5.35 | - |
DIS
006890
0939
600051
ORXGF
NOA